Rezolute, Inc. Common Stock (NV)(RZLT)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

RZLT iron condor setups RZLT expected move RZLT IV rank history RZLT Fibonacci levels RZLT insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

RZLT $3.90 —
Snapshot
$3.90
52-Week Range
$1.07 – $11.46
YTD
+80.14%
IV Rank (30D)
40.74
Straddle Price
$2.52
P/C Vol Ratio
1.06
Market Cap
$0.4B
Fair Value
-34.1% vs price

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.96%
Beta vs SPY0.84
Cost of Equity (CAPM)9.14% (VRP-adj)
WACC9.20%
Volatility Risk Premium+182.0pp (IV − HV30)
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.1B
Return on Equity (TTM)-69.7%
Book / Price30.6% — banking bias active (P/B is primary)
Debt / Equity0.00
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$4.59 (Market Anchor value)
SMA 20 / Bollinger Mid$4.27
Bollinger Width / SMA20682.3% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: ALMS, CRVS, GPCR (filtered from 8 ETF-co-members; sector bias active)
Blended Fair Value
$2.57
Deviation
-34.1%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B $2.57 100% median 2.1× · 3 peers
Peer P/S n/a 0%
Market Anchor (SMA50) $4.59 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-09-25 · updated
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$0.4B

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objecti…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan +19.27% 6
Feb -7.32% 6
Mar -1.40% 6
Apr +6.52% 6
May +16.12% 6
Jun +13.01% 6
Jul -1.42% 6
Aug -5.28% 6
Sep +0.91% 6
Oct -12.09% 5
Nov -10.26% 6
Dec -13.53% 6
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $4.21
SMA 50: $4.58
SMA 200: $3.73
Current: $3.90
EMA 12: $4.06
EMA 26: $4.26
MACD: -0.2047 | Signal: -0.0173
BEARISH
ADX (14): 25.19
TREND
+DI: 12.57
−DI: 24.84

Momentum Oscillators

RSI (14): 35.34
NEUTRAL
Stoch %K: 30.14
Stoch %D: 32.37
Williams %R: -73.45

Volume & Volatility

BB Upper: $4.76
BB Lower: $3.67
NEUTRAL
OBV: 1,242,728
Vol SMA 20: 1,464,764
Vol ROC: 51.30%
ATR: $0.25
True Range: $0.18
HV 20: 50.0%
HV 30: 50.9%
HV 60: 60.3%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-09-27T00:00:00 – 2026-09-25T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

This report provides a comprehensive stock analysis of RZLT (Rezolute, Inc.) based on technical indicators, options metrics, beta analysis, market data, and recent news headlines. The overall assessment is NEUTRAL with a confidence level of 6 out of 10.

Key drivers include the company's participation in upcoming investor conferences, which could generate positive sentiment. Primary risks are related to the stock's high volatility, negative news sentiment, and potential regulatory issues.

The investment thesis is that RZLT's recent news headlines suggest a range-bound trading environment, with potential for increased volatility around earnings announcements.

Recent news sentiment has been negative, driven by trial failures and lead asset setbacks. However, the company's participation in investor conferences could shift this sentiment positively.

Technical Analysis

Trend Direction: The short-term trend is NEUTRAL, while the medium-term trend is BEARISH. The long-term trend remains UPTRENDING.

Support/Resistance Levels: Key price levels are $3.25 (SMA 20), $3.19 (SMA 50), and $3.07 (Bollinger Bands Lower).

Momentum Signals:

  • RSI interpretation: NEUTRAL (52.76)
  • MACD signal: BULLISH (0.01 / Signal: 0.00 / Histogram: 0.01)
  • Bollinger Bands position: NEUTRAL (price touching middle band)

Volume Analysis: Volume trends indicate a range-bound trading environment, with low institutional interest.

News & Sentiment Analysis

Recent Headlines Summary: The news headlines suggest a negative sentiment, driven by trial failures and lead asset setbacks. However, the company's participation in investor conferences could shift this sentiment positively.

Sentiment Assessment: Aggregate news sentiment is NEGATIVE.

Catalyst Identification: Upcoming investor conferences and potential earnings announcements could generate positive catalysts.

Market Narrative: The recent news headlines contradict the technical signals, indicating a range-bound trading environment with potential for increased volatility around earnings announcements.

Risk & Volatility Assessment

Beta Interpretation: Beta is 1.00 (vs SPY), indicating above-average volatility and amplification of market movements.

Volatility Regime: Current volatility is HIGH (1.24), which may persist due to recent news headlines and market uncertainty.

Options Market Signals: IV Rank is LOW (15.2%), suggesting historical low volatility, while the put/call volume ratio is BEARISH (40.67).

Downside Protection: Support levels are $3.25 (SMA 20) and $3.19 (SMA 50), with potential for a bounce if the stock reaches these levels.

Market Context & Positioning

Sector Performance: RZLT's sector is performing NEUTRALLY, which may impact its trading range.

Institutional Activity: Low institutional interest suggests a lack of support or resistance from larger investors.

Correlation Analysis: The stock moves with the market (0.10), indicating an amplification of market movements.

Relative Valuation: RZLT is trading within its historical range, with potential for increased volatility around earnings announcements.

Key Levels & Action Items

Critical Price Levels: Support levels are $3.25 (SMA 20) and $3.19 (SMA 50), while resistance is at the upper Bollinger Bands level ($3.42).

Breakout/Breakdown Levels: A breakout above the upper Bollinger Bands level could generate a bullish signal, while a breakdown below the lower Bollinger Bands level could indicate increased selling pressure.

Time-Sensitive Catalysts: Upcoming investor conferences and earnings announcements could generate positive catalysts.

Risk Management: Stop-loss levels should be set at $3.19 (SMA 50), with position sizing considerations based on recent news headlines and market uncertainty.

By analyzing the technical indicators, options metrics, beta analysis, market data, and recent news headlines, this report provides a comprehensive assessment of RZLT's stock performance and potential for future price movements. The report highlights key drivers, primary risks, and catalysts that could impact the stock's trading range.

Generated
Earnings History
7 of 7 under expected move
Avg Expected Move
24.95%
Avg Actual Move
4.62%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-11-07 After-Close 20.94% 4.60% 0.22x Within
2025-02-12 After-Close 15.91% 1.23% 0.08x Within
2025-05-13 After-Close 33.92% 5.29% 0.16x Within
2025-09-17 After-Close 14.92% 6.36% 0.43x Within
2025-11-06 After-Close 29.89% 9.67% 0.32x Within
2026-02-12 After-Close 32.56% 4.26% 0.13x Within
2026-05-12 After-Close 26.52% 0.91% 0.03x Within
Options Activity
IV Rank (30D)
40.74
IV Rank (7D)
40.74
Avg IV
232.0%
Straddle (30D)
$2.52
Straddle (7D)
$2.52
P/C Volume
1.06
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.99
Correlation (SPY)
10.1%
R²
0.01
Ann. Volatility
127.2%
SPY Volatility
13.0%

Moderate volatility - stock generally follows market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-06-30
Diluted shares outstanding: 103,907,114 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

145 filers91,457,670 shares$460.13M value88.02% of float
# Filer Shares Value % of Total % of Float Period
1 FEDERATED HERMES, INC. 12,990,659 $67.55M 14.68% 12.50% 2026-06-30
2 RA CAPITAL MANAGEMENT, L.P. 9,445,039 $49.11M 10.67% 9.09% 2026-06-30
3 BlackRock, Inc. Custodian 7,718,291 $40.14M 8.72% 7.43% 2026-06-30
4 Opaleye Management Inc. 6,300,000 $32.76M 7.12% 6.06% 2026-06-30
5 BALYASNY ASSET MANAGEMENT L.P. 4,662,039 $24.24M 5.27% 4.49% 2026-06-30
6 VANGUARD CAPITAL MANAGEMENT LLC 3,835,827 $19.95M 4.33% 3.69% 2026-06-30
7 Siren, L.L.C. 3,328,287 $17.31M 3.76% 3.20% 2026-06-30
8 JACOBS LEVY EQUITY MANAGEMENT, INC 2,561,654 $13.32M 2.90% 2.47% 2026-06-30
9 JENNISON ASSOCIATES LLC 2,459,308 $12.79M 2.78% 2.37% 2026-06-30
10 VANGUARD GROUP INC Custodian 4,788,511 $11.30M 2.46% 4.61% 2025-12-31
11 GEODE CAPITAL MANAGEMENT, LLC Custodian 2,170,154 $11.29M 2.45% 2.09% 2026-06-30
12 STATE STREET CORP 1,850,128 $9.62M 2.09% 1.78% 2026-06-30
13 D. E. Shaw & Co., Inc. Custodian 1,839,357 $9.56M 2.08% 1.77% 2026-06-30
14 MORGAN STANLEY Custodian 1,618,783 $8.42M 1.83% 1.56% 2026-06-30
15 VANGUARD PORTFOLIO MANAGEMENT LLC 1,380,746 $7.18M 1.56% 1.33% 2026-06-30
16 GOLDMAN SACHS GROUP INC Custodian 1,316,782 $6.85M 1.49% 1.27% 2026-06-30
17 Nuveen, LLC Custodian 1,295,209 $6.74M 1.46% 1.25% 2026-06-30
18 KENNEDY CAPITAL MANAGEMENT LLC 1,221,678 $6.35M 1.38% 1.18% 2026-06-30
19 Blackstone Inc. 1,082,927 $5.63M 1.22% 1.04% 2026-06-30
20 AQR CAPITAL MANAGEMENT LLC Custodian 1,007,962 $5.24M 1.14% 0.97% 2026-06-30
21 Affinity Asset Advisors, LLC 1,000,000 $5.20M 1.13% 0.96% 2026-06-30
22 GREAT POINT PARTNERS LLC 951,809 $4.95M 1.08% 0.92% 2026-06-30
23 Ikarian Capital, LLC 935,012 $4.86M 1.06% 0.90% 2026-06-30
24 DIMENSIONAL FUND ADVISORS LP Custodian 890,733 $4.63M 1.01% 0.86% 2026-06-30
25 22NW, LP 820,653 $4.27M 0.93% 0.79% 2026-06-30
7 filers$16.08M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $7.77M 48.35% 2026-06-30
2 Squadron Capital Management LLC $4.68M 29.11% 2026-06-30
3 SIMPLEX TRADING, LLC Custodian $1.21M 7.51% 2026-06-30
4 CITADEL ADVISORS LLC Custodian $957.32K 5.95% 2026-06-30
5 Centiva Capital, LP $822.64K 5.12% 2026-06-30
6 Caption Management, LLC $520.00K 3.23% 2026-06-30
7 GROUP ONE TRADING LLC Custodian $115.96K 0.72% 2026-06-30
4 filers$1.06M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $488.28K 46.19% 2026-06-30
2 SIMPLEX TRADING, LLC Custodian $358.28K 33.89% 2026-06-30
3 CITADEL ADVISORS LLC Custodian $208.00K 19.68% 2026-06-30
4 GROUP ONE TRADING LLC Custodian $2.60K 0.25% 2026-06-30
Insider Activity
Latest: 2026-09-03
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-09-03 Sunil Ratilal Karnawat Chief Commercial Officer Tax (F) −2,267 $4.50 -$10.2K EDGAR
2026-07-07 BRIAN KENNETH ROBERTS Chief Medical Officer Tax (F) −3,062 $4.99 -$15.3K EDGAR
2026-07-07 Nevan C Elam CEO Tax (F) −8,004 $4.99 -$39.9K EDGAR
2026-07-07 Daron Evans CFO Tax (F) −3,062 $4.99 -$15.3K EDGAR
2026-03-04 Nevan C Elam CEO Tax (F) −27,618 $2.99 -$82.6K EDGAR
2026-03-04 BRIAN KENNETH ROBERTS Chief Medical Officer Tax (F) −11,439 $2.99 -$34.2K EDGAR
2026-03-04 Daron Evans CFO Tax (F) −11,438 $2.99 -$34.2K EDGAR
2025-12-17 BRIAN KENNETH ROBERTS Chief Medical Officer Buy (P) +28,000 $1.70 $47.6K EDGAR
2025-12-17 Wladimir Hogenhuis Director Buy (P) +5,650 $1.69 $9.5K EDGAR
2025-12-15 Sunil Ratilal Karnawat Chief Commercial Officer Buy (P) +12,100 $1.62 $19.6K EDGAR
2025-12-15 Nevan C Elam CEO Buy (P) +32,000 $1.59 $50.9K EDGAR
2025-12-15 Daron Evans CFO Buy (P) +45,000 $1.77 $79.6K EDGAR
2025-11-21 Erik Harris Director Award (A) +21,000 — EDGAR
2025-11-21 PHILIPPE FAUCHET Director Award (A) +21,000 — EDGAR
2025-11-21 Gil M Labrucherie Director Award (A) +21,000 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
11 insiders · @ $3.90
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Young-Jin Kim Director 8,594,336 $33.52M $9.37M 6 2025-11-21
2 HANDOK, INC. Director 2,784,722 $10.86M $17.00M 1 2024-03-19
3 Nevan C Elam CEO 605,497 $2.36M $94.3K 12 2026-07-07
4 Daron Evans CFO 418,400 $1.63M $664.7K 19 2026-07-07
5 BRIAN KENNETH ROBERTS Chief Medical Officer 309,351 $1.21M $247.4K 21 2026-07-07
6 Wladimir Hogenhuis Director 119,675 $466.7K $261.3K 11 2025-12-17
7 Gil M Labrucherie Director 109,072 $425.4K $400.0K 8 2025-11-21
8 Sunil Ratilal Karnawat Chief Commercial Officer 71,173 $277.6K $19.6K 4 2026-09-03
9 NERISSA KREHER Director 58,576 $228.4K $10.0K 7 2025-11-21
10 PHILIPPE FAUCHET Director 55,500 $216.4K $0 6 2025-11-21
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio3.8
EV/EBITDA-4.5
TTM Net Income$-0.1B
TTM EPS$-0.76
ROE-77.1%